Table 4.

Proportion of subjects in each risk category in eMERGE

Cancer type	Sample size (N)	Low‐risk (GRS <0.5)	Average‐risk (GRS:0.5‐1.5)	High‐risk (GRS >1.5)
Bladder	13 427	2.08%	91.20%	6.73%
Breast	7020	15.16%	69.43%	15.41%
Colorectal	13 427	5.12%	84.34%	10.55%
Glioma	13 427	16.37%	69.25%	14.38%
Lung	13 427	0.10%	97.15%	2.75%
Melanoma	13 427	9.14%	76.43%	14.43%
Ovarian	7020	4.56%	83.45%	11.99%
Pancreatic	13 427	2.97%	86.71%	10.32%
Prostate	6407	19.88%	63.96%	16.15%
Renal	13 427	1.49%	92.36%	6.15%
Thyroid	13 427	7.92%	82.07%	10.01%

GRS, genetic risk score.